glp 1 and colon cancer GLP-1s show 'mind-blowing' effect on colorectal risk GLP-1 drugs may reduce the

Retatrutide, a triple-hormone agonist, has been shown in Phase 2 trials to be extremely effective in inducing weight loss in a dose-dependent manner.42 Given the potential extraordinary economic and composite health benefits to the individual and population, it seems likely that the area of Bariatric Pharmacology will continue to expand

WW: Methodology, Writing review & editing

Another effect of decreased GI motility is reflux, or GERD

However, the significantly greater weight reduction associated with GLP-1 based therapies and their proven health benefits (e.g., reduction in cardiovascular disease with semaglutide [29] and improved sleep apnea with tirzepatide [30]), as well as a wider acceptance that medication is needed for sustained weight reduction success, has triggered a rapid surge in their uptake [31]

It helps manage blood sugar by triggering insulin release and reducing glucagon